In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery


KAHAN A., Topuz S. , Saip P., Sozen H., Salihoglu Y.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, cilt.20, ss.31-36, 2019 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/jtgga.galenos.2018.2018.0015
  • Dergi Adı: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Sayfa Sayıları: ss.31-36

Özet

Objective: It is known that optimal or complete cytoreduction is the most important factor in patients with advanced ovarian cancer. The aim of this study was to examine the results of patients who did not undergo optimal cytoreduction and to examine subgroup analysis based on neoadjuvant chemotherapy (NAC).